Yi Sheng Pharmaceutical and other two new shares

Yi Sheng Pharmaceutical co., Yi Sheng (002566) February 28 evening announced the offer letter of intent, March 9 implementation of the purchase. The company intends to issue 27.6 million shares, the total share capital after the issuance of 110 million shares.　　The company under the network issue accounted for the number of the issue of 20%, that is, 5.52 million shares, the number of online distribution for the total amount of this issue minus the net under the final issue quantity, that is, 22.08 million shares. The company is mainly engaged in the development, production and sales of proprietary Chinese medicine.　　2008-2010, respectively, the realization of operating income of 311 million yuan, 414 million yuan and 516 million yuan, the owner of the parent company net profit is 41.3666 million yuan, 61.1287 million yuan and 87.6379 million yuan respectively.　　Shanghai Green New Shanghai Green (002565) February 28 announced the announcement of interest, March 9 implementation of the purchase. The company intends to issue no more than 33.5 million shares, after the issuance of total equity not exceeding 133 million shares.　　The number of shares issued by the company under this network does not exceed 6.7 million shares, accounting for 20% of the total number of shares issued, and the total number of shares issued on the internet minus the final circulation of the net, that is, 26.8 million shares. The company's main business is to engage in vacuum aluminized paper, white cardboard, laminating paper, smoke and other products such as the development, production, processing and sales. 2008-2010, the company realized operating income of 681 million yuan, 699 million yuan and 823 million yuan respectively, the shareholder net profit of listed companies is 78.2951 million yuan, 96.7597 million yuan and 103 million yuan respectively.